Objectives This study aims to evaluate the effect of adding bone substitute materials (BSM) to particulated autogenous bone (PAB) on the volume fraction (Vf) of newly formed bone after maxillary sinus augmentation. Materials and methods Thirty healthy patients undergoing maxillary sinus augmentation were included. PAB (N010), mixtures of PAB and beta-tricalciumphosphate (PAB/β-TCP) (N010), as well as PAB and β-TCP and hydroxyapatite (PAB/HA/β-TCP) (N010) were randomly used for sinus augmentation. A sample of the graft material was maintained from each patient at time of maxillary sinus augmentation, and Vfs of the PAB and/or BSM in the samples were determined by means of microcomputerized tomography (μ-CT). Five months later, samples of the grafted areas were harvested during implantation using a trephine bur. μ-CT analysis of these samples was performed, and the Vf of bone and BSM were compared with the data obtained 5 months earlier from the original material.
Introduction
The severely atrophic posterior maxilla can successfully be treated by maxillary sinus augmentation as described by Boyne and James or Tatum [1] [2] [3] [4] [5] [6] prior to implant placement. Though many studies have documented the suitability of different materials for maxillary sinus augmentation, such as autogenous bone, biomaterials, or combinations of both [7] [8] [9] [10] [11] [12] [13] , it still remains widely unknown which material is the most favorable [14] [15] [16] .
Regardless of the material used for augmentation, the structure of the graft after healing must provide a microarchitecture that allows a sufficient implant anchorage through osseointegration. The mechanical stability of osseointegrated implants is dependent on the quality and quantity of the adjacent bone and its biomechanical properties. Therefore, obtaining a maximum of bone quantity is one of the key goals in augmentative implant surgery.
Many studies have evaluated the amount of newly formed bone following maxillary sinus augmentation with different grafting materials in histological sections of samples retrieved several months after lateral antrostomy [14, [17] [18] [19] [20] [21] [22] . Though autogenous bone is still regarded as standard for grafting [23, 24] , it could be shown that a remarkable amount of newly formed bone is obtainable when substitute materials are used alone [18, 25] . Since it is well known that autogenous bone has osteoinductive properties [26, 27] , the question arises as to whether mixtures of bone and BSM result in a similar amount of newly formed bone when used for maxillary sinus augmentation as for autogenous bone alone.
When adding autogenous bone to substitute materials for maxillary sinus augmentation, the correct determination of the amount of newly formed bone in histological samples presents a challenge because the volumetric distribution and amount of bone and substitute material at the time of maxillary sinus augmentation is unknown. μ-CT was successfully used to visualize and evaluate the volumetric distribution of bone and substitute materials in bony samples retrieved after maxillary sinus augmentation [28] . As a non-invasive technique, μ-CT might also be suitable to evaluate the volumetric distribution of bone and BSM in a particulated form, e.g., the particulated graft at the time of maxillary sinus augmentation. Comparing the volumetric distributions of bone and BSM at the time of sinus augmentation with the volumetric distributions in samples retrieved several months after healing has not been performed until now. This allows the determination of changes in the volumes of bone and substitute material over time. The working hypothesis is that adding BSM to PAB results in a smaller amount of newly formed bone volume 5 months after maxillary sinus augmentation when compared to the use of PAB alone.
Materials and methods
The study protocol was approved by the ethics committee of the Johannes Gutenberg University of Mainz (No. 837.158.08 (6155)).
Patients
Thirty consecutive, systemically healthy patients (17 female, 13 male; mean age 54; range 36-79) who presented for maxillary sinus augmentation were included in this study. Informed consent was obtained from all patients prior participation in this study. Exclusion criteria were advanced systemic diseases, osteoporosis, pregnancy, infectious diseases, radiation, corticosteroid and bisphosphonate medication, chemotherapy, and smoking.
Before surgical treatment, patients were randomly enrolled in one of the following treatment groups:
Group A: Mixture of blood, particulated autogenous bone (PAB), and β-TCP (N010). Group B: Mixture of blood, PAB, and β-TCP/HA (N010). Group C: Mixture of blood and PAB (N010).
Surgical procedure
A mucoperiosteal flap was elevated and access to the sinus membrane was achieved by drilling an oval hollow into the facial sinus wall with a diamond bur. The bone in the center of the drilled window was gently infractured and the intact Schneiderian membrane was elevated. Once the Schneiderian membrane was completely mobilized, the infractured bone was folded inwards and upwards, imitating a trapdoor effect.
Autogenous bone was harvested as a block either from the chin or the linea obliqua externa and particulated using a surgical bone mill (Quetin bone mill®, Quetin Dental Products, Leimen, Germany). The particulated bone was mixed with blood, and BSM was added in a ratio of approximately 1:1. β-TCP (Cerasorb® 1,000-2,000 μm, Curasan AG, Kleinostheim, Germany) was used in group A (N010) and a β-TCP/HA mixture (Straumann® BoneCeramic 500-1,000 μm; Institut Straumann AG, Basel, Switzerland) in group B (N 010). In group C (N010), only PAB and blood were used without any additional BSM.
A sample of approximately 0.5 cm 3 of each particulated graft was collected at the time of sinus augmentation and maintained in a standard polypropylene snap-lock tube (Eppendorf Safe-Lock Tubes® 0.5 ml, Eppendorf AG, Hamburg, Germany). For plugging the graft into the tubes, the same forces as for the maxillary sinus augmentation were applied as far as possible. They were plugged by one of the two oral surgeons (S.K. and M.K) with more than 10 years of professional experience who performed the maxillary sinus augmentations. The samples were fixed with buffered, paraformaldehyde fixative solution (Roti Histofix® 4.5 %; Carl Roth GmbH + Co KG, Karlsruhe, Germany), and μ-CT of the filled snap-lock tubes was performed.
Bony cylinders were harvested from the grafted areas during implant placement 5 months after maxillary sinus augmentation by means of a trephine bur with an internal diameter of 3.2 mm (Fig. 1) . The cylinders were gently removed from the trephine and immediately immersed in 4.5 % buffered, pH 7.0 paraformaldehyde fixative (Roti Histofix 4.5 %; Carl Roth GmbH + Co KG, Karlsruhe, Germany) for at least 7 days. After dehydrating in alcohol in ascending ethanol series, the cylinders were embedded in paraffin according to standard protocols (Hypercenter XP, Shandon, Frankfurt am Main, Germany) and a μ-CT examination was performed.
A total of 46 samples were evaluated (23 samples of the particulated graft maintained at time of sinus augmentation and 23 bony samples retrieved 5 months after healing). Seven patients were consecutively excluded from the study: one of group A, two of group B, and two of group C because of insufficient sample retrieval at re-entry. Two patients were additionally excluded from group C because of steroid medication after maxillary sinus augmentation.
μ-CT
All analyses were carried out using a high-resolution μ-CT with a nominal isotropic resolution of 6×6×6 μm 3 voxelsize (SCANCO® μ-CT 40, SCANCO Medical AG, Brüttisellen, Switzerland) at identical settings (70 kV, 113 μA, 0.18°an-gular increment, 300 ms integration time).
Each polypropylene snap-lock tube containing the particulated bone or bone and substitute material was clamped into a specimen holder of the μ-CT for examination.
The paraffin-embedded samples retrieved 5 months later were placed into conical pipette tips (100 μl MBP Pipet Tips No. 3550, Molecular Bioproducts, Inc., USA), such that the tips held the samples through an interference fit. The pipette was then fixed in a specimen holder of the μ-CT for examination avoiding movements.
Three-dimensional reconstructions of the μ-CT data were performed (Figs. 2 and 3) based on thresholds for bone and substitute material according to histogram distribution of grey values described in a previous study of Kühl et al. [28] . The thresholds for bone were set at 280-550 mgHA/cm 3 (representing the intermediatedensity material) and at 550-1,000 mgHA/cm 3 (representing high-density material) for the BSM. Following the segmentation process, a morphological filter operation by means of dilatation and erosion in the border zones of the substitute materials was applied prior to the evaluation with the SCANCO imaging software in order to reduce artefacts. For volume analysis, a volume of interest was first determined, in which the alveolar bone was not included. Based on the segmentation process, the volume of bone (Vb) and the volume of BSM (Vsm) were separately evaluated within the volume of interest. Percentage distribution of bone (Vfb) and BSM (Vfsm) were calculated as volume fractions by dividing Vb or Vsm by the volume of interest.
Statistical analyses
The mean percentage volume fraction of bone (Vfb) and BSM (Vfsm), including standard deviation (SD), were calculated for each group at the time of maxillary sinus augmentation and again 5 months later. An analysis of variance was performed to evaluate statistically significant differences between the individual groups with regard to the changes of Vfb and Vfsm between the two points in time (at time of maxillary sinus augmentation and 5 months later) and between each group. Significance was considered to be p<0.05. The statistical analyses were performed with a statistics package (SPSS).
Results
The Vfsm decreased in both groups 5 months after sinus augmentation (Table 1 ) from a mean Vfsm of 8.9 % to 5.1 % in group A and from 10.1 % to 5.0 % in group B (Fig. 4) . Based on the data obtained, a power analysis was performed showing a level of <80 % for both groups.
In contrast to this, the Vfb showed a statistically significant increase 5 months after maxillary sinus augmentation in all groups (Table 2) , whereas the Vfb increased by a mean of 17.1 % in group A, by a mean of 21.7 % in group B, and by 18.5 % in group C (Fig. 5) . The increase of bone between the groups showed no statistically significant differences at p>0.05 (Table 2 ). The power analysis showed a level of significance >80 %. 
Discussion
The volume distribution of bone, the bone density, and the bone stability stand in close relationship one to another. BSM has no mechanical stability in its particulated form. To gain biomechanical stability, it has to be surrounded by bone: the greater the bone volume, the higher the strength will be. The volume of newly formed bone is therefore an important aspect in comparing different grafting materials. Beside volume, the bone quality plays a key role in biomechanical stability. The bone quality is generally determined by evaluating the bone's density. Bone stability grows with increasing density. Taking this into account, it is of special clinical interest to evaluate both volume and density of the bone obtained after grafting with different materials. The current investigation using μ-CT revealed a statistically Fig. 2 3D reconstructions after segmentation of the μ-CT data for a sample maintained at the time of maxillary sinus augmentation of group A (upper row) B (middle row), and C (lower row). The bone is green and the BSM particles are gray. The left image shows the structure of the grafts' total volume at the time of maxillary sinus augmentation; the middle and right images, respectively, show longitudinal and cross-sectional slices through the particulated grafts significant increase in the percentage of bone 5 months after maxillary sinus augmentation for three different grafting materials. Autogenous bone is regarded as standard for grafting procedures because of its osteoinductive properties [23, 26, 27] . It was therefore expected that the amount of newly formed bone might be negatively affected by adding bone substitute material particles providing osteoconductive properties only. Frenken et al. [25] used a mixture of HA/β-TCP (Straumann® Bone Ceramic) without adding autogenous bone for maxillary sinus augmentation. After an Fig. 3 3D reconstructions after segmentation of the μ-CT data of a sample of group A (upper row), group B (middle row), and C (lower row) retrieved 5 months after maxillary sinus augmentation. The bone is green and the BSM is gray. The volume of the bone and the BSM were calculated according to the segmentation average healing time of 6 months, the ratio bone volume to total volume was measured to be 27.3 % in histological samples. As no autogenous bone was used in this study, the newly formed bone represents the effective bone volume increase 6 months after maxillary sinus augmentation. In contrast to this, Cordaro et al. [18] , in a similar study, found a rate of newly formed bone of 19.8 % with the same HA/β-TCP (Straumann Bone Ceramic®) substitute material. As it is known that autogenous bone has osteoinductive properties, the combination of autogenous bone and substitute materials was expected to be beneficial with regard to the obtained volume of newly formed bone in our study. In our study, however, the effective volume of newly formed bone -i.e., the difference between the bone volume within the grafts at the time of sinuslift procedure and the samples retrieved 5 months later-was measured to be 21.7 %. This indicates a lower bone formation rate than in the study published by Frenken et al. and a slightly higher value than in the study of Cordaro et al. [18, 25] . The reason for this discrepancy might be related to the different mean healing time of approximately 4 weeks between the studies with the shortest healing times for the study of Cordaro et al. [18] . Artzi et al. [29] found that the percentage amount of newly formed bone increases over an extended healing period. In their study, autogenous bone and HA/β-TCP were mixed at a ratio of 1:1, and bony samples were retrieved 6 and 9 months after grafting the maxillary sinus. The amount of newly formed bone increased from 28.6 % after 6 months to 41.6 % after an average healing time of 9 months. Based on these observations, it can be assumed that the measured Vfb in our study would also have been higher than 24.8 % with a longer healing period.
The bone volume ingrowth of 17.1 % for group A (β-TCP, Cerasorb®) was the smallest, resulting in a Vfb of 21.4 %. Artzi et al. [19] used a mixture of β-TCP (Cerasorb®) and autogenous bone in a clinical study for maxillary sinus augmentation and found an average bone area fraction of 32 % after a healing time of 12 months. This difference to our study may also be related to the longer healing time.
Suba et al. [22] performed a study on bilateral sinuslift, using autogenous particulated bone on one side and β-TCP (Cerasorb®) on the other. In contrast to the above findings, the trabecular bone volume was 32.4 % for the experimental side (Cerasorb®) and 34.7 % for the control sides in samples retrieved 6 months after sinus augmentation. As observed in Table 1 Percentage volume of bone substitute materials (Vfsm) for both groups: A 0 autogenous bone + β-TCP and B 0 autogenous bone + β-TCP/HA at different stages (t00at time of maxillary sinus augmentation; t105 months after maxillary sinus augmentation) (number of samples (N), minimum, maximum, mean and standard deviation (SD)) our study, the bone volume ingrowth was smaller for the β-TCP group than for the control group with autogenous bone alone.
In comparison to groups A and B, the bone ingrowth in group C (autogenous bone alone) was measured to be 18.5 %, resulting in a bone Vfb of 25.53 %, which represents the highest bone volume to total volume value of the three groups. The higher amount of bone volume might be explained by the higher Vfb of 7.0 % at the time of maxillary sinuslift in comparison to group A (4.3 %) and group B (3.1 %). Taking this into consideration, the effective bone volume ingrowth of 18.5 % ranges between the effective bone ingrowth of groups A (17.1 %) and B (21.7 %).
The data revealed that there is no statistically significant difference in Vf in any of the groups. The reason for the same ingrowth in all groups cannot be determined by this study. Obviously in the present clinical setup, BSM showed sufficient osteogenic potential to support similar bone ingrowth as seen in controls. In agreement with data from other studies, our findings seem to support clinical application of BSM for sinus grafting procedures. Additionally, BSM have shown less tendency for resorption in clinical long-term applications compared to autogenous bone grafts and may potentially be beneficial with regard to donor site, harvest morbidity, and patients' acceptance.
Our data indicate that using mixtures of autogenous bone and β-TCP or mixtures of PAB and HA/β-TCP as well as Table 2 Percentage volume of bone (Vfb) for all groups: A 0 autogenous bone + β-TCP, B 0 autogenous bone + β-TCP/HA and C 0 autogenous bone at different stages (t00at time of maxillary sinus augmentation; t105 months after maxillary sinus augmentation) (number of samples (N), minimum, maximum, mean and standard deviation (SD)) 
